Navigation Links
First Bellwether Trial in Federal DePuy ASR Lawsuit Litigation Scheduled to Begin after Two-Week Postponement
Date:9/22/2013

New York, NY (PRWEB) September 22, 2013

The first federal trial for a DePuy ASR hip lawsuit (http://www.depuy-asr-hip-recall.com/) is scheduled to begin Tuesday in the U.S. District Court, Northern District of Ohio, Bernstein Liebhard LLP reports.

According to an Order issued September 6th by the federal judge overseeing the litigation, the trial is set to commence on September 24, 2013 at 9:00 a.m. after being postponed for two weeks pending additional discovery and further consideration of legal matters relevant to the case. The start date for this DePuy ASR hip lawsuit, which was selected to serve as the proceeding’s first bellwether trial in July, had originally been scheduled for September 9th.

Included in this case are claims filed by a Rochester, New York woman whose alleged injuries caused by the DePuy ASR metal-on-metal hip replacement forced her to undergo revision surgery to remove the device. (McCracken v. DePuy Orthopaedics Inc., et al., No. 1:11-dp-20485)

Court records indicate that over 8,000 claims filed by individuals affected by the DePuy ASR recall are now pending in the federal litigation underway in the Northern District of Ohio.

“Our Firm is representing hundreds of individuals who were allegedly injured as a result of the DePuy ASR metal-on-metal hip. We are looking forward to the start date of this trial, as it may serve as an indicator of how juries will rule in similar actions involving the DePuy ASR recall,” says Bernstein Liebhard LLP, a nationwide law firm representing individuals who have been injured by defective drugs and medical devices. The Firm is currently offering free and confidential case evaluations to anyone who may have suffered serious complications allegedly due to devices affected by the DePuy ASR recall.

DePuy ASR Recall

The DePuy ASR hip recall was issued in August 2010 after data from a United Kingdom hip registry showed annual revision rates associated with the metal implant to be unacceptably high within five years of implantation, according to the U.S. Food and Drug Administration. Court records indicate that some 11,000 lawsuits alleging pain, swelling, difficulty walking and other symptoms associated with metallosis (metal ion poisoning) have since been filed by individuals affected by the recall in the U.S.

In addition to lawsuits pending in federal court, DePuy ASR recall cases are moving forward in various state courts as well. In a proceeding underway in California Superior Court, a trial is slated to begin on October 15th (DePuy ASR HIP System Cases, No. CJC-10-004649; Calif. Super. Ct., San Francisco Cty), while another case over the DePuy ASR hip implant has been scheduled for trial in New Jersey Superior Court on October 21st. (In Re DePuy ASR Hip Implants Litigation, BER-L-3971-11)

DePuy ASR lawsuits similarly allege that the metal-on-metal hip was defectively designed by DePuy Orthopaedics, which failed to warn doctors and patients about its product’s potential to fail prematurely.

Two trials involving the DePuy ASR hip recall have already concluded. In March 2013, a jury in Los Angeles Superior Court awarded $8 million to a plaintiff whose lawyers argued that the metal hip was defectively designed by the manufacturer. (Kransky v. DePuy, BC456086, California Superior Court, Los Angeles County) A jury in Chicago ruled in favor of the Johnson & Johnson subsidiary a month later in a second trial over the ASR device. (Strum v. DePuy, 2011-L-9352, Circuit Court of Cook County)

Individuals who allegedly experienced metallosis, premature device failure or other complications after the DePuy ASR hip recall may be eligible to receive compensation for medical bills, lost wages, pain and suffering, and other damages. Learn more about filing a DePuy ASR lawsuit by visiting Bernstein Liebhard LLP’s website. Please contact one of our attorneys for a free and confidential case review by calling 800-511-5092.

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.depuy-asr-hip-recall.com/

Read the full story at http://www.prweb.com/releases/depuy-asr-recall/depuy-asr-hip-lawsuit/prweb11139159.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Yogis Rejoice: Sports Club/LA is the First Health Club to Bring Strala Yoga to its Premier Clubs Across the Country
2. CRF announces late breaking trials and first report investigations to be presented at TCT 2013
3. Della Shea of Symcor Selected as Canada’s First Information Security Executive® of the Year
4. Eco Orange Will Release Its First YouTube Commercial Soon
5. Loma Linda University Children’s Hospital Patient Visits KFROG Radiothon, First Public Outing in 10 Months
6. MySecretLuxury.com Celebrates Successful First Year as Discerning Consumers Seek out the Best Adult Toys
7. Leading Seattle Carpet Cleaning Company First Class Carpet Service Now Providing Online Quotes
8. First-Ever West Coast 24 Hour SEAL Adventure Challenge Now Open for Registration in California
9. DePuy ASR Hip Replacement Lawsuit Trial: Jury Selection in First Federal Trial of DePuy ASR Hip Recall Lawsuit to Begin on September 24th, Wright & Schulte LLC Reports
10. HUMAN Healthy Vending Expands Into 73 New Markets in 90 Days, Launches Industry-First Healthy Micro-Market Platform
11. First Choice Emergency Room Opens Facility in Deer Park, Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... ... "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic technologies, and ... maintaining fulfilling lives. “We are prolonging life 6 years in the last 3 ...
(Date:12/2/2016)... ... 2016 , ... The PAINWeekEnd Regional Conference will be hosted ... Honolulu, offering local frontline clinicians the opportunity to extend their certified continuing medical ... supplemental training related to pain management has surged dramatically in recent years, with ...
(Date:12/2/2016)... ... , ... Sourced from the Isbre Springs beneath the 5,000 year old Hardanger ... of just 6 ppm TDS (Total Dissolved Solids) in addition to its excellent taste ... several ShopRite and FoodTown stores in NJ and received rave comments from consumers. , ...
(Date:12/2/2016)... ... December 02, 2016 , ... Yisrayl Hawkins, at The House ... this current generation fits into Bible Prophecy. Yisrayl says this generation, known as the ... this conclusion, showing how the details line up exactly with Bible Prophecy – a ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... announced today that it has raised $6.0 million in an initial round of ... Health’s conviction that patients and their caregivers can receive far better care through ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Dec. 2, 2016  The Addiction Treatment Advisory ... of Managed Care Pharmacy (AMCP), has released detailed ... address the opioid addiction crisis, including through improved ... ATAG,s newly released paper, "The Role ... Naloxone," addresses many issues around gaps and barriers ...
(Date:12/2/2016)... 2016 CVS Health Corporation (NYSE: ... York City on Thursday, December 15, 2016, beginning at 8:00 a.m. (ET). ... provide an in-depth review of the company,s strategies to ... will also discuss 2017 earnings guidance during the event. ... event will be broadcast simultaneously on the Investor Relations ...
(Date:12/2/2016)... 2, 2016   CytoSorbents Corporation (NASDAQ: ... European Union approved CytoSorb ® cytokine adsorber to ... worldwide, announced that Dr. Phillip Chan , Chief ... LD Micro Main Event investor conference held from ... Luxe Sunset Boulevard Hotel in Los Angeles, ...
Breaking Medicine Technology: